| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2971075 | The Journal of Heart and Lung Transplantation | 2010 | 5 Pages |
Abstract
Standard dosing of enoxaparin in lung transplant recipients is associated with a high incidence of supratherapeutic anti-Xa levels. Further study will be required to correlate this finding with risk of hemorrhage.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jonathan P. MD, MS, Meng-Yu PharmD, Christine PharmD, Paul D. MD, MPH, Rebecca F. PharmD, Jeffery MD, Katherine PharmD, Charles MD, Lorriana E. MD,